Smitha Mellacheruvu, MD - ECHO Associates

A Beacon of Light on Your Cancer Care Journey

EASTERN CONNECTICUT HEMATOLOGY & ONCOLOGY ASSOCIATES

Smitha Mellacheruvu, MD

Dr. Mellacheruvu was born in India. She received her Bachelor of Medicine and Bachelor of Surgery at Osmania Medical College in India. She came to the United States in 2000 and completed her internal medicine internship and residency at UCONN School of Medicine. After residency, she completed a fellowship in Hematology-Oncology from the Montefiore Medical Center, Albert Einstein College of Medicine in New York. She then went on to serve as a fellow/ clinical lecturer at the University of Michigan in their division of bone marrow transplantation. 

After her training, Dr. Mellacheruvu served as an attending physician in the Division of Hematologic Malignancies and Bone Marrow Transplantation at Montefiore Medical Center in New York. In 2011 she joined a private hematology/ oncology practice in New York where she spent 7 years. Since 2018, she has served as an attending physician in oncology and hematology at Montefiore Einstein Center for Cancer Care, St. Johns Riverside Hospital in Yonkers, and most recently at Northern Westchester Hospital.

Throughout her career, Dr. Mellacheruvu has been highly regarded for excellence. Since 2014, she has been a Castle Connolly “Top Doctor” which recognizes the top 7% of all U.S. practicing physicians. She has been featured in New York Magazine and Westchester Magazine as one of the top doctors in the New York area. She has also been recognized nationally on the Exceptional Women in Medicine list since 2020. In addition, she received pandemic service awards for her outstanding commitment during the COVID 19 pandemic.

Dr. Mellacheruvu has published on topics related to blood-related cancers and stem cell transplantation. She also has lectured on topics including breast cancer risk factors and prevention strategies. 

She is thrilled to join ECHO in June of 2024. She looks forward to joining the team and sharing her expertise with patients throughout Connecticut.

Dr. Mellacheruvu will start to see patients at ECHO in mid-July.

Education

Undergraduate & Medical School: Bachelor of Medicine and Bachelor of Surgery, Osmania Medical College, Hyderabad, India

Internship & Residency: Internal Medicine, University of Connecticut Health Center, Farmington, CT

Fellowship: Hematology-Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY

Fellow/ Clinical lecturer: Division of Bone Marrow Transplantation, University of Michigan, Ann Arbor, MI

Board Certifications

  • Hematology
  • Medical Oncology

Commendations

  • Exceptional Women in Medicine: 2020, 2021, 2022, 2023, 2024
  • Top Doctors New York Metro Area (book series) 18th Edition
  • Westchester Magazine Top Doctors: 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023
  • Top Doctors New York Metro Area (digital guide): 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023
  • New York Magazine Top Doctors: 2021, 2022, 2023

Publications

Mellacheruvu S, Sayegh M N, Sica R A, et al. Lymphomatous Meningitis from Anaplastic Lymphoma Kinase + Anaplastic Large T cell Lymphoma Treated with Lorlatinib: A Case Report. JCO Precision Oncology. 2022 Feb 9: e2100250. doi: 10.1200/ PO. 21.00250

Khaled Y, Mellacheruvu S, Reddy P, Peres E, Mineishi S: Longterm outcomes of myeloablative allogeneic transplantation for multiple myeloma compared to autologous transplantation and the impact of graft versus myeloma effect. Bone Marrow Transplant. 2009 Sep.; 44 (5): 325-6

Mellacheruvu S and Vergara C: Hemolytic Anemia in a patient with fulminant hepatic failure. Connecticut Medicine. Vol. 70, No.4, 163-165, April 2006

Zaldivar MC, Mellacheruvu S, Kaplan AA, Adams ND: Increased incidence of Hemodialysis catheter infections associated with intravenous iron administration. American Journal of Kidney Diseases: A35, 2002

Kato K, Mellacheruvu S, Mineishi S: chapter III. The evolving role of Hematopoietic Stem Cell Transplant in Non-Hodgkins Lymphoma. pp 71-108. Hematopoietic Stem Cell Transplant Research Advances